GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Monday, 20 Apr 2015 | 7:10 PM ET

    Amgen Inc. rose $2.39 or 1.5 percent, to $165.97. Biogen Idec rose $3.48 or. 8 percent, to $422.92. Celgene Corp. rose $1.28 or 1.1 percent, to $114.75.

  • Midday Glance: Biotechnology companies Monday, 20 Apr 2015 | 1:17 PM ET

    Amgen Inc. rose $1.43 or. 9 percent, to $165.01. Biogen Idec rose $3.07 or. 7 percent, to $422.51. Celgene Corp. rose$. 76 or. 7 percent, to $114.23.

  • Early Glance: Biotechnology companies Monday, 20 Apr 2015 | 10:38 AM ET

    Amgen Inc. rose $1.18 or. 7 percent, to $164.77. Biogen Idec rose $2.38 or. 6 percent, to $421.82. Celgene Corp. rose$. 53 or. 5 percent, to $114.00.

  • Final Glance: Biotechnology companies Friday, 17 Apr 2015 | 6:03 PM ET

    Amgen Inc. fell $3.29 or 2.0 percent, to $163.58. Biogen Idec fell $9.21 or 2.1 percent, to $419.44. Celgene Corp. fell $2.89 or 2.5 percent, to $113.47.

  • Midday Glance: Biotechnology companies Friday, 17 Apr 2015 | 1:17 PM ET

    Amgen Inc. fell $4.27 or 2.6 percent, to $162.60. Biogen Idec fell $8.80 or 2.1 percent, to $419.85. Celgene Corp. fell $2.47 or 2.1 percent, to $113.89.

  • Early Glance: Biotechnology companies Friday, 17 Apr 2015 | 10:57 AM ET

    Amgen Inc. fell $3.39 or 2.0 percent, to $163.48. Biogen Idec fell $7.44 or 1.7 percent, to $421.21. Celgene Corp. fell $2.02 or 1.7 percent, to $114.34.

  • Final Glance: Biotechnology companies Thursday, 16 Apr 2015 | 6:03 PM ET

    Amgen Inc. rose $1.40 or. 8 percent, to $166.87. Biogen Idec fell $2.31 or. 5 percent, to $428.65. Celgene Corp. fell $1.87 or 1.6 percent, to $116.36.

  • Midday Glance: Biotechnology companies Thursday, 16 Apr 2015 | 1:28 PM ET

    Amgen Inc. rose $1.15 or. 7 percent, to $166.62. Biogen Idec fell$. 01 or percent, to $430.95. Celgene Corp. fell $1.65 or 1.4 percent, to $116.58.

  • Final Glance: Biotechnology companies Wednesday, 15 Apr 2015 | 5:57 PM ET

    Amgen Inc. rose $2.90 or 1.8 percent, to $165.47. Biogen Idec rose $7.39 or 1.7 percent, to $430.96. Celgene Corp. rose $2.45 or 2.1 percent, to $118.23.

  • Midday Glance: Biotechnology companies Wednesday, 15 Apr 2015 | 2:34 PM ET

    Amgen Inc. rose $1.99 or 1.2 percent, to $164.56. Biogen Idec rose $6.10 or 1.4 percent, to $429.67. Celgene Corp. rose $1.68 or 1.5 percent, to $117.46.

  • Final Glance: Biotechnology companies Tuesday, 14 Apr 2015 | 5:58 PM ET

    Amgen Inc. rose$. 08 or percent, to $162.57. Biogen Idec rose$. 21 or percent, to $423.57. Celgene Corp. fell$. 66 or. 6 percent, to $115.78.

  • Midday Glance: Biotechnology companies Tuesday, 14 Apr 2015 | 1:34 PM ET

    Amgen Inc. fell$. 70 or. 4 percent, to $161.79. Biogen Idec fell $3.32 or. 8 percent, to $420.04. Celgene Corp. fell $1.10 or. 9 percent, to $115.34.

  • Early Glance: Biotechnology companies Tuesday, 14 Apr 2015 | 10:42 AM ET

    Amgen Inc. fell $1.12 or. 7 percent, to $161.37. Biogen Idec fell $3.22 or. 8 percent, to $420.14. Celgene Corp. fell$. 43 or. 4 percent, to $116.01.

  • A record 4.3 billion prescriptions were filled in 2014, many of them for inexpensive generic pills going to patients now insured through Medicaid in states that expanded eligibility for the government health program for the poor and disabled. The number of prescriptions covered by Medicaid rose by nearly 17 percent, and that increase accounted for 70...

  • Demand for newer cancer and multiple sclerosis treatments, price increases on branded medicines, particularly insulin products for diabetes, and the entry of few new generic versions of big-selling drugs also contributed to the double-digit spending rise in 2014, the report by IMS Health Holdings Inc found. "We certainly expect to see growth in the market...

  • Final Glance: Biotechnology companies Monday, 13 Apr 2015 | 6:00 PM ET

    Amgen Inc. fell$. 89 or. 5 percent, to $162.49. Biogen Idec fell $2.29 or. 5 percent, to $423.36. Celgene Corp. fell$. 63 or. 5 percent, to $116.44.

  • Midday Glance: Biotechnology companies Monday, 13 Apr 2015 | 1:19 PM ET

    Amgen Inc. fell$. 05 or percent, to $163.33. Biogen Idec rose $1.39 or. 3 percent, to $427.04. Celgene Corp. rose$. 52 or. 4 percent, to $117.59.

  • Early Glance: Biotechnology companies Monday, 13 Apr 2015 | 10:27 AM ET

    Amgen Inc. rose$. 71 or. 4 percent, to $164.09. Biogen Idec rose $4.25 or 1.0 percent, to $429.89. Celgene Corp. rose$. 35 or. 3 percent, to $117.42.

  • Specialty, generic drug costs drive Medicaid costs up Saturday, 11 Apr 2015 | 12:32 PM ET

    JEFFERSON CITY, Mo.— The high cost of a drug used to treat Medicaid patients with hepatitis C drew scrutiny from lawmakers earlier this year, but other drugs are also driving up the state's costs and likely will continue to do so for several years, government data reveals. From fiscal year 2010 through 2014, drug costs for Missouri's Medicaid program rose 33...

  • Final Glance: Biotechnology companies Friday, 10 Apr 2015 | 6:05 PM ET

    Amgen Inc. rose $1.89 or 1.2 percent, to $163.38. Biogen Idec fell$. 98 or. 2 percent, to $425.65. Celgene Corp. rose $1.49 or 1.3 percent, to $117.07.